Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Motor Neuron Disease Association has published a blog post from Martin Turner about 'BioMOx', the Oxford Study for Biomarkers in MND.

Between 2009 and 2013, over 70 people living with MND (and some healthy people of similar age for comparison), took part in a new type of patient-based study. Men and women of all ages (from 28 to 86), some with primary lateral sclerosis (PLS) as well as a range of the more common amyotrophic lateral sclerosis (ALS) types, all gave up their time to attend for a day or two of tests in Oxford.

Read full text...

More about Martin Turner

More about BioMOx

Similar stories

John Jacob wins clinical academic research partnership for brain cancer project

The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.

Newborn brain scans clarify how some diseases develop

Newborn brain scans from the Developing Human Connectome Project are now available online in large-scale open-source project, clarifying how some diseases develop.

New consortium to uncover mechanisms of neuropathic pain

Professor David Bennett is leading a new national research consortium to investigate neuropathic pain.

NDCN Thomas Willis Day Prize Winners

Our annual Thomas Willis Day celebrates the work of our Department over the previous year.